清脆的
大流行
2019年冠状病毒病(COVID-19)
诊断试验
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
重症监护医学
疾病
病毒学
冠状病毒
医学
生物
传染病(医学专业)
病理
儿科
遗传学
爆发
基因
作者
Saeedeh Ebrahimi,Hashem Khanbabaei,Samaneh Abbasi,Mona Fani,Saber Soltani,Milad Zandi,Zahra Najafimemar
出处
期刊:Avicenna journal of medical biotechnology
[Knowledge E]
日期:2022-01-01
被引量:8
标识
DOI:10.18502/ajmb.v14i1.8165
摘要
More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.
科研通智能强力驱动
Strongly Powered by AbleSci AI